Positive Updated Results from MajesTEC-1 Study in Relapsed/Refractory Multiple Myeloma
![Positive Updated Results from MajesTEC-1 Study in Relapsed/Refractory Multiple Myeloma](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/94bbcd9383e135a83910351743c22620.jpg)
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Ajay K. Nooka, MD, Associate Professor of Hematology and Medical Oncology at Emory School of Medicine, discusses the updated efficacy and safety results from the phase 1/2 MajesTEC-1 study evaluating...
show moreMultiple myeloma is a rare blood cancer associated with uncontrolled growth of plasma cells. Abnormal plasma cells – also known as myeloma cells – interfere with the production of healthy blood cells in the bone marrow. Symptoms of multiple myeloma may include: bone pain (particularly in the chest and spine), frequent infections, weakness or numbness in the legs, fatigue, confusion, excessive thirst, and constipation. While the disease is treatable, relapses are common and some patients are refractory to first line, and subsequent, therapies.
Information
Author | Peter Ciszewski, CheckRare |
Organization | CheckRare |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company